Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology.
GRB-associated binding protein 2 (GAB2) represents a compelling genome-wide association signal for late-onset Alzheimer's disease (LOAD) with reported odds ratios (ORs) ranging from 0.75-0.85. We tested eight GAB2 variants in four North American Caucasian case-control series (2,316 LOAD, 2,538...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0064802&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849434062808154112 |
|---|---|
| author | Fanggeng Zou Olivia Belbin Olivia Belbin Minerva M Carrasquillo Oliver J Culley Talisha A Hunter Li Ma Gina D Bisceglio Mariet Allen Dennis W Dickson Neill R Graff-Radford Ronald C Petersen Genetic and Environmental Risk for Alzheimer’s disease (GERAD1) Consortium Kevin Morgan Steven G Younkin |
| author_facet | Fanggeng Zou Olivia Belbin Olivia Belbin Minerva M Carrasquillo Oliver J Culley Talisha A Hunter Li Ma Gina D Bisceglio Mariet Allen Dennis W Dickson Neill R Graff-Radford Ronald C Petersen Genetic and Environmental Risk for Alzheimer’s disease (GERAD1) Consortium Kevin Morgan Steven G Younkin |
| author_sort | Fanggeng Zou |
| collection | DOAJ |
| description | GRB-associated binding protein 2 (GAB2) represents a compelling genome-wide association signal for late-onset Alzheimer's disease (LOAD) with reported odds ratios (ORs) ranging from 0.75-0.85. We tested eight GAB2 variants in four North American Caucasian case-control series (2,316 LOAD, 2,538 controls) for association with LOAD. Meta-analyses revealed ORs ranging from (0.61-1.20) with no significant association (all p>0.32). Four variants were hetergeneous across the populations (all p<0.02) due to a potentially inflated effect size (OR = 0.61-0.66) only observed in the smallest series (702 LOAD, 209 controls). Despite the lack of association in our series, the previously reported protective association for GAB2 remained after meta-analyses of our data with all available previously published series (11,952-22,253 samples; OR = 0.82-0.88; all p<0.04). Using a freely available database of lymphoblastoid cell lines we found that protective GAB2 variants were associated with increased GAB2 expression (p = 9.5×10(-7)-9.3×10(-6)). We next measured GAB2 mRNA levels in 249 brains and found that decreased neurofibrillary tangle (r = -0.34, p = 0.0006) and senile plaque counts (r = -0.32, p = 0.001) were both good predictors of increased GAB2 mRNA levels albeit that sex (r = -0.28, p = 0.005) may have been a contributing factor. In summary, we hypothesise that GAB2 variants that are protective against LOAD in some populations may act functionally to increase GAB2 mRNA levels (in lymphoblastoid cells) and that increased GAB2 mRNA levels are associated with significantly decreased LOAD pathology. These findings support the hypothesis that Gab2 may protect neurons against LOAD but due to significant population heterogeneity, it is still unclear whether this protection is detectable at the genetic level. |
| format | Article |
| id | doaj-art-80b2970086f84b61ab6022bd35c4c8a0 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-80b2970086f84b61ab6022bd35c4c8a02025-08-20T03:26:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6480210.1371/journal.pone.0064802Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology.Fanggeng ZouOlivia BelbinOlivia BelbinMinerva M CarrasquilloOliver J CulleyTalisha A HunterLi MaGina D BisceglioMariet AllenDennis W DicksonNeill R Graff-RadfordRonald C PetersenGenetic and Environmental Risk for Alzheimer’s disease (GERAD1) ConsortiumKevin MorganSteven G YounkinGRB-associated binding protein 2 (GAB2) represents a compelling genome-wide association signal for late-onset Alzheimer's disease (LOAD) with reported odds ratios (ORs) ranging from 0.75-0.85. We tested eight GAB2 variants in four North American Caucasian case-control series (2,316 LOAD, 2,538 controls) for association with LOAD. Meta-analyses revealed ORs ranging from (0.61-1.20) with no significant association (all p>0.32). Four variants were hetergeneous across the populations (all p<0.02) due to a potentially inflated effect size (OR = 0.61-0.66) only observed in the smallest series (702 LOAD, 209 controls). Despite the lack of association in our series, the previously reported protective association for GAB2 remained after meta-analyses of our data with all available previously published series (11,952-22,253 samples; OR = 0.82-0.88; all p<0.04). Using a freely available database of lymphoblastoid cell lines we found that protective GAB2 variants were associated with increased GAB2 expression (p = 9.5×10(-7)-9.3×10(-6)). We next measured GAB2 mRNA levels in 249 brains and found that decreased neurofibrillary tangle (r = -0.34, p = 0.0006) and senile plaque counts (r = -0.32, p = 0.001) were both good predictors of increased GAB2 mRNA levels albeit that sex (r = -0.28, p = 0.005) may have been a contributing factor. In summary, we hypothesise that GAB2 variants that are protective against LOAD in some populations may act functionally to increase GAB2 mRNA levels (in lymphoblastoid cells) and that increased GAB2 mRNA levels are associated with significantly decreased LOAD pathology. These findings support the hypothesis that Gab2 may protect neurons against LOAD but due to significant population heterogeneity, it is still unclear whether this protection is detectable at the genetic level.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0064802&type=printable |
| spellingShingle | Fanggeng Zou Olivia Belbin Olivia Belbin Minerva M Carrasquillo Oliver J Culley Talisha A Hunter Li Ma Gina D Bisceglio Mariet Allen Dennis W Dickson Neill R Graff-Radford Ronald C Petersen Genetic and Environmental Risk for Alzheimer’s disease (GERAD1) Consortium Kevin Morgan Steven G Younkin Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology. PLoS ONE |
| title | Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology. |
| title_full | Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology. |
| title_fullStr | Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology. |
| title_full_unstemmed | Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology. |
| title_short | Linking protective GAB2 variants, increased cortical GAB2 expression and decreased Alzheimer's disease pathology. |
| title_sort | linking protective gab2 variants increased cortical gab2 expression and decreased alzheimer s disease pathology |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0064802&type=printable |
| work_keys_str_mv | AT fanggengzou linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT oliviabelbin linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT oliviabelbin linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT minervamcarrasquillo linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT oliverjculley linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT talishaahunter linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT lima linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT ginadbisceglio linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT marietallen linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT denniswdickson linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT neillrgraffradford linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT ronaldcpetersen linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT geneticandenvironmentalriskforalzheimersdiseasegerad1consortium linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT kevinmorgan linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology AT stevengyounkin linkingprotectivegab2variantsincreasedcorticalgab2expressionanddecreasedalzheimersdiseasepathology |